Pinnacle Financial Group, Inc.’s Jasper Therapeutics JSPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$725 Buy
+42
New +$847 ﹤0.01% 2114

Other funds holding JSPR

Pinnacle Financial Group, Inc.'s JSPR Position: Q3 2026 in Review

Pinnacle Financial Group, Inc. opened a new position in Jasper Therapeutics (JSPR) in Q3 2026: 42 shares worth $725. The stake represents ﹤0.01% of the portfolio and ranks #2114 among its holdings.

49 funds tracked by Wall St. Rank hold JSPR as of Q3 2026.

  • Pinnacle Financial Group, Inc. held 42 shares of Jasper Therapeutics worth $725 as of Q3 2026.
  • Jasper Therapeutics was a new Pinnacle Financial Group, Inc. position in Q3 2026.
  • Jasper Therapeutics made up ﹤0.01% of Pinnacle Financial Group, Inc.'s portfolio in Q3 2026, its #2114 holding.
  • 49 funds tracked by Wall St. Rank held Jasper Therapeutics as of Q3 2026.

Based on Pinnacle Financial Group, Inc.'s 13F filing for Q3 2026, filed 16 Nov 2026.